MKIs inhibit both cell growth and tumor angiogenesis through the suppression of angiogenic receptor tyrosine kinases such as FGFR, vascular endothelial growth factor (VEGF) receptor (VEGFR) and platelet-derived growth factor receptor38. The gene discussed is KDR; the disease is neoplasm.